Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion type Assertion NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_head.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion description "[Furthermore, knocking down of CXCR4 using RNA interference or inhibition of CXCR4 function by an antagonist AMD3100 not only reduced VEGF production by CD133(+) GSCs in vitro, but also attenuated the growth and angiogenesis of tumour xenografts in vivo formed by CD133(+) GSCs in SCID mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_provenance.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion evidence source_evidence_literature NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_provenance.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion SIO_000772 21618540 NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_provenance.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion wasDerivedFrom befree-20140225 NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_provenance.
- NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_assertion wasGeneratedBy ECO_0000203 NP562116.RAVm6yEx0bh55Z1QqdLnhOHmH2ng6uZrthCRGXu-pnmgM130_provenance.